Your session is about to expire
← Back to Search
Postoperative Hip Precautions for Osteoarthritis
N/A
Recruiting
Led By Brett Levine, MD, MS
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients undergoing a primary total hip arthroplasty via the posterior approach by participating attending surgeons at this institution
Index diagnosis of noninflammatory arthritis
Must not have
History of previous surgeries on the affected joint other than arthroscopy; i.e. revision THA or open surgeries
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks after surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial will help determine if hip precautions after surgery help prevent hip dislocation and improve patient satisfaction.
Who is the study for?
This trial is for patients with noninflammatory arthritis who are having their first total hip replacement through the posterior approach. They must understand and follow study procedures but can't join if they have allergies to materials used in the study or previous major surgeries on the affected joint.
What is being tested?
The study is testing whether following 'hip precautions' after a hip replacement surgery affects dislocation rates, recovery of daily activities, patient satisfaction, and cost-effectiveness compared to not using these precautions.
What are the potential side effects?
Since this trial compares lifestyle instructions rather than medications, traditional side effects aren't expected. However, there may be differences in comfort levels or mobility challenges between groups.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am having my first total hip replacement surgery through the back of the hip by a surgeon from this hospital.
Select...
My arthritis is not caused by inflammation.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had surgery on the affected joint, but only arthroscopy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks after surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Dislocation
Secondary study objectives
Activities of Daily Living
Other study objectives
Use of Assistive Devices After Surgery
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: No Hip PrecautionsExperimental Treatment1 Intervention
Patients will not be prescribed hip precautions in the first 6 weeks after surgery. The hip precautions that will no longer be prescribed are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.
Group II: Hip PrecautionsActive Control1 Intervention
Patients will receive the following hip precautions: no hip flexion past 90º, no crossing the legs, and no twisting at the waist for the first six weeks after surgery.
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
436 Previous Clinical Trials
248,364 Total Patients Enrolled
25 Trials studying Osteoarthritis
2,238 Patients Enrolled for Osteoarthritis
Brett Levine, MD, MS4.8237 ReviewsPrincipal Investigator - Assistant Professor
Rush University Medical Center
5Patient Review
I feel so lucky to have found Dr Levine and his team. They were able to help me through my surgery and recovery with such ease and care. I was originally drawn to him because he came highly recommended as a physician who worked with challenging cases, but what really won me over was his team's respect for my concerns and their dedication to keeping me well informed. I also loved the daily educational text support — it gave me a step-by-step guide of valuable information that was crucial for my successful recovery. With Dr Levine and his team, I know I'm in good hands for my next surgery.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had surgery on the affected joint, but only arthroscopy.I am having my first total hip replacement surgery through the back of the hip by a surgeon from this hospital.My arthritis is not caused by inflammation.
Research Study Groups:
This trial has the following groups:- Group 1: Hip Precautions
- Group 2: No Hip Precautions
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger